Icon (ICLR) Gains from Sales and Divestitures (2009 - 2025)
Icon's (ICLR) quarterly Gains from Sales and Divestitures came in at -$1.9 million in Q4 2025, down 159.58% year-over-year from $3.2 million in Q4 2024, and down 159.58% quarter-over-quarter from $3.2 million in Q4 2024.
Powered by 
Analysis
Icon (ICLR) Gains from Sales and Divestitures (2009 - 2025) Analysis & Trends
Icon (ICLR) has reported Gains from Sales and Divestitures for 16 consecutive years, with -$1.9 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Gains from Sales and Divestitures fell 159.58% year-over-year to -$1.9 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 60.49% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 76.59% from the prior year.
- Gains from Sales and Divestitures was -$1.9 million for Q4 2025 at Icon, down from $3.2 million in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $3.2 million in Q4 2024 and troughed at -$1.9 million in Q4 2025.
- A 4-year average of $270000.0 and a median of -$5000.0 in 2021 frame the typical range for Gains from Sales and Divestitures.
- Across the five-year window, Gains from Sales and Divestitures surged 2094.97% in 2024 and tumbled 159.58% in 2025, its largest moves.
- Over 4 years, Gains from Sales and Divestitures stood at -$5000.0 in 2021, then plunged by 3080.0% to -$159000.0 in 2023, then surged by 2094.97% to $3.2 million in 2024, then plunged by 159.58% to -$1.9 million in 2025.
- The last three Gains from Sales and Divestitures figures came in at -$1.9 million (Q4 2025), $3.2 million (Q4 2024), and -$159000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | -159,000.00 |
| Sep 30, 2023 | 232,000.00 |
| Mar 31, 2021 | -5,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 58,000.00 |
| Mar 31, 2020 | 37,000.00 |
| Dec 31, 2019 | 129,000.00 |
| Sep 30, 2019 | 188,000.00 |
| Jun 30, 2019 | 29,000.00 |
| Dec 31, 2018 | 61,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Dec 31, 2017 | 43,000.00 |
| Sep 30, 2017 | -163,000.00 |
| Jun 30, 2017 | 348,000.00 |
| Dec 31, 2016 | 124,000.00 |
| Jun 30, 2016 | 20,000.00 |